India's Natco Pharma ties up with Gilead on hepatitis C drugs
March 02, 2015 at 01:40 AM EST
MUMBAI, March 2 (Reuters) - India's Natco Pharma Limited said on Monday it signed a licensing deal with Gilead Sciences Inc to make and sell generic versions of the U.S. drugmaker's chronic hepatitis C medicines.
